Frontiers in Microbiology is a leading open-access journal published by Frontiers Media SA, available since 2010, and based in Switzerland. As a prominent platform for innovative research, it specializes in microbiology and medical microbiology, marked by its impressive Q1 classification in the respective fields, reflecting its significant impact and relevance in advancing microbial sciences. With a Scopus ranking of 49th in Microbiology and 41st in Medical Microbiology, this journal is positioned among the top-tier publications, catering to a diverse audience of researchers, professionals, and students. The journal aims to disseminate groundbreaking findings and foster discussions that drive the field forward, ensuring a comprehensive coverage of microbiological studies, from basic research to applications in healthcare and beyond. Enjoy unrestricted access to cutting-edge articles that contribute to both theoretical and applied aspects of microbiology, enriching the scientific community's knowledge base.

Welcome to the Jundishapur Journal of Microbiology, a peer-reviewed publication dedicated to advancing the field of microbiology. Published by BRIEFLAND, this journal focuses on key areas such as infectious diseases and medical microbiology, offering a platform for researchers to share their findings from 2009 to 2024. Despite its current positioning in Quartile 4 across various categories in 2023, the journal provides a valuable resource for budding scientists and established professionals alike, contributing to the growing body of knowledge in these critical areas. While it is not an open-access journal, the Jundishapur Journal prioritizes the dissemination of research in the Netherlands, facilitating a deeper understanding of microbial science and its implications for public health. Join a community of innovators committed to exploring both emerging and established themes in microbiology.

Comparative Immunology Microbiology and Infectious Diseases, published by Elsevier Science Ltd, is a prominent journal dedicated to advancing the fields of immunology, microbiology, infectious diseases, and veterinary sciences. Established in 1978, this journal has become a vital resource for researchers and professionals alike, with a commendable impact factor that reflects its significance in academia. The journal, available in both print and electronic formats (ISSN: 0147-9571, E-ISSN: 1878-1667), stands out for its commitment to disseminating innovative research findings, particularly through its categorization in Q2 and Q3 quartiles across various related disciplines as of 2023. The journal aims to provide insightful comparative analyses that enhance our understanding of host-pathogen interactions, immune responses, and disease manifestations. With a global readership base, it serves as a platform for collaborative discourse among scientists and professionals, ultimately contributing to the improvement of health outcomes worldwide.

MICROBIOLOGICAL RESEARCH, published by Elsevier GmbH, serves as a leading platform for advancements in the field of Microbiology, holding an impressive Q1 ranking in its category as of 2023. With an ISSN of 0944-5013 and E-ISSN 1618-0623, this journal has been instrumental in disseminating high-quality research since its inception in 1994 and continues to contribute significantly to the academic landscape through 2024. Positioned within the top 13% of publications in the Immunology and Microbiology category, ranked #24 out of 182 according to Scopus, it attracts the attention of researchers, professionals, and students alike. While the journal is not open access, it offers vital insights and peer-reviewed articles that drive innovation and exploration within microbiological research. Its rigorous selection process underscores the importance of quality and relevance in advancing knowledge in this dynamic field.

Advancements of Microbiology, published by the Polish Society of Microbiologists, serves as a vital resource for researchers and professionals in the field of microbiology. With an ISSN of 0079-4252 and an E-ISSN of 2545-3149, this esteemed journal provides Open Access content, facilitating the dissemination of innovative scientific research since 2018. Although coverage in Scopus has been discontinued since 2018, the journal is recognized for its historical contributions, ranging from 1973 to 1982 and 1999 to 2018. Positioned within the Microbiology (medical) category, it currently ranks #97 out of 110, while its standing in Immunology and Microbiology reflects a rank of #127 among 140 journals. Advancements of Microbiology emphasizes cutting-edge findings and applications, catering to an audience dedicated to advancing knowledge and practice in the ever-evolving microbiological landscape.

Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.

The BRAZILIAN JOURNAL OF MICROBIOLOGY, published by SPRINGER, stands as a pivotal platform in the field of microbiology, offering an open access model since 2000. With the ISSN 1517-8382 and E-ISSN 1678-4405, this esteemed journal encourages the dissemination of groundbreaking research and innovative methodologies that contribute to the understanding of microbial life, its role in health and disease, and its environmental impact. Based in Switzerland and accessible globally, the journal’s categorization in the Q3 quartile for Microbiology reflects its commitment to quality and relevance in the scientific community. As of 2023, it ranks 121 out of 182 in the Scopus listings for Microbiology, further highlighting its growing influence in immunology and microbiological research. With converged years spanning from 1992 to 2024, the journal continues to support a diverse range of studies, making it an invaluable resource for researchers, professionals, and students alike.

Current Research in Microbial Sciences is a distinguished peer-reviewed journal published by Elsevier, focusing on the dynamic and rapidly advancing fields of microbiology and infectious diseases. With an ISSN of 2666-5174, this journal has established itself as an essential resource for researchers, professionals, and students alike, offering the latest findings and insights from 2020 to 2024. The journal holds a significant position in the academic landscape, achieving a Q2 ranking across multiple categories, including Immunology and Microbiology, Infectious Diseases, and Medical Microbiology, demonstrating its impact in these critical areas of study. With impressive Scopus rankings—such as being placed in the 94th percentile for Immunology and Microbiology—current research is well-supported by a thriving scientific community. Although the journal is not open access, it serves as a vital platform for disseminating high-quality research and fostering collaboration within the microbial sciences. Engaging with this journal enables professionals and researchers to stay abreast of innovations and contribute to the collective body of knowledge that shapes our understanding of microbial interactions and infectious diseases.

Welcome to mLife, an emerging journal at the forefront of microbiological research published by the esteemed WILEY in China. With its ISSN 2097-1699 and E-ISSN 2770-100X, mLife serves as a vital platform for scholars and practitioners aiming to advance their understanding of microbial sciences. With an impressive Q2 ranking in the Microbiology category and a Scopus rank of 143 out of 182, mLife is quickly establishing itself as a valuable source of cutting-edge research. The journal, covering a range of innovative topics from immunology to environmental microbiology, provides an engaging venue for disseminating high-quality research findings aimed at addressing real-world challenges. Authors and readers alike benefit from its accessibility features that encourage scholarly collaboration and information sharing. As we converge on the rich microbial landscapes from 2022 to 2024, mLife is committed to fostering a community dedicated to rigorous research and impactful discoveries.

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.